Beam Therapeutics (BEAM) Key Ratios

Stock Card

$29.66

$0.20 (0.68%)

As on 04-Sep-2026 16:25EDT

Market cap

$3,064 Mln

Revenue (TTM)

$156 Mln

P/E Ratio

P/B Ratio

2.9

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	-98.46	-94.21	158.88	24.86	478.90
EBIT	-38.29	-27.51	79.29	20.39	12.06
Net Profit	-30.07	-19.93	78.57	20.25	12.36
EPS	-28.74	-17.25	80.93	21.86	13.39
Book Value	--	--	33.26	4.43	23.68

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	TTM	Dec-25	Dec-24
EBIT-Margin	-217.91	-316.16	-52.90	-25.95	-593.06
Net Margin	--	-503.10	-54.75	--	--
Return on equity	-22.50	-34.74	-7.41	-8.11	-43.94
Return on Capital	-18.73	-28.53	--	-6.59	-36.77
Return on Assets	-15.01	-20.81	-5.63	-6.19	-29.39
Debt to Equity (x)	--	--	0.09	0.24	0.22

Profitability

View Detailed Peer Comparison

ROCE

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	--	-6.59	-36.77	-12.83	-30.64	-55.84
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROE

-7.41

Higher than Peers by 32.99

Profit after tax / Average Net worth * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	-7.41	-8.11	-43.94	-15.46	-37.06	-69.13
Peer Median	-40.40	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROA

-5.63

Higher than Peers by 25.34

Profit after tax / Average Total assets * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	-5.63	-6.19	-29.39	-9.46	-20.53	-38.49
Peer Median	-30.98	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EBIT Margin

-52.90

Higher than Peers by 30.72

Operating profit (EBIT) / Net Sales * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	-52.90	-25.95	-593.06	-34.73	-468.94	-458.13
Peer Median	-83.62	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Margin

-54.75

Higher than Peers by 37.92

Net profit / Total Income (Net sales plus other income) * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	-54.75	-57.24	-593.13	-35.09	-474.54	-503.10
Peer Median	-92.67	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Cash Profit Margin

0.00

Higher than Peers by 0.00

(Net profit + Depreciation) / Gross Sales * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	0.00	--	--	--	--	--
Peer Median	0.00	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

158.88

Higher than Peers by 104.93

Year on year growth in net sales

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	158.88	1.20	-0.83	5.20	0.18	2,159.17
Peer Median	53.95	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EBIT Growth

79.29

Higher than Peers by 80.09

Year on year growth in operating profit (EBIT)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	79.29	90.37	-187.21	54.09	-20.28	-78.90
Peer Median	-0.80	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Profit Growth

78.57

Higher than Peers by 85.87

Year on year growth in profit after tax

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	78.57	78.77	-184.28	54.16	22.00	-90.47
Peer Median	-7.30	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EPS Growth

80.93

Higher than Peers by 66.28

Year on year growth in earnings per share

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	80.93	0.83	-1.84	0.61	0.25	-0.69
Peer Median	14.65	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Book Value Growth

-0.31

Higher than Peers by 9.87

Year on year growth in book value per share

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	-0.31	--	--	--	--	--
Peer Median	-10.18	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.09

Total debt / Net worth

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	0.09	0.24	0.22	0.18	0.24	0.18
Peer Median	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Short term debt to equity ratio

0.01

(Short term borrowings / Net worth)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	0.01	0.01	0.02	0.01	0.01	0.01
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Current Ratio

14.57

Higher than Peers by 8.76

Current Assets / Current Liabilities and Provisions

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	14.57	13.09	4.82	5.89	4.89	5.96
Peer Median	5.81	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Quick Ratio

14.57

Higher than Peers by 8.88

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	14.57	--	--	--	--	8.81
Peer Median	5.70	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Interest Coverage

-1.20

Higher than Peers by 0.89

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	-1.20	-0.83	-7.67	-2.81	-18.68	-26,390.22
Peer Median	-2.09	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

Debtors outstanding / Net Sales * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	--	--	--	--	--	578.66
Peer Median	19.14	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Asset Turnover

0.10

Higher than Peers by 0.04

Sales / Average Total Assets

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	0.10	0.11	0.05	0.27	0.04	0.05
Peer Median	0.06	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Receivable days

Average Debtors / Sales * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	--	--	--	--	899.34	1,056.78
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Inventory Days

Average Inventory / Sales * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	--	--	--	--	-711.95	-955.65
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Payable days

Average Creditors / Cost of goods sold * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	--	115.52	2.73	4.45	9.67	10.85
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Cash Conversion Cycle

Receivable Days + Inventory Days - Payable Days

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	--	--	--	--	177.72	90.28
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

Current share price divided by earning per share in the last twelve months

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	--	-36.36	-5.45	-16.99	-9.58	-14.62
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Price / Book Value

2.85

Lower than Peers by 2.33

Current share price divided by book value per share in the latest financial year

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	2.85	2.35	2.80	2.29	3.77	6.55
Peer Median	5.18	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Dividend Yield

Dividend per share in the past twelve months divided by current share price

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	--	--	--	--	--	--
Peer Median	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EV/EBITDA

-7.03

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	-7.03	-65.41	-3.85	-12.14	-6.88	-19.99
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Market Cap

3,064

Higher than Peers by 2,917

Current Share price multiplied by latest total number of shares outstanding

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-13
Beam Therapeutics (BEAM)	3,064	--	--	--	--	--
Peer Median	146	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly